ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1919

Patient-reported Social Risk Factor Screening Among Rheumatology Outpatients

Alissa Chandler1, Mohammed Hamid2, Aurora Jiao3, Kelsey Hulcher4, Isha Sharma5, Patrice Odom4, Andrew Robinson6, Sara Kellahan2, Maura Kepper7, Colleen Dostal8, Senada Fenelon9, Seth Eisen10, Daphne Lew11 and Alfred Kim12, 1Washington University, St. Louis, MO, 2Washington University School of Medicine, St. Louis, MO, 3Washington University, Saint Louis, 4Washington University, Saint Louis, MO, 5Washington University in St. Louis School of Medicine, San Jose, CA, 6Washington University, Fenton, MO, 7Washington University, Brown School of Social Work, Saint Louis, 8Southern Illinois University Edwardsville, St. Louis, MO, 9Washington University St Louis, Ballwin, MO, 10Washington University School of Medicine, St Louis, MO, 11Center for Biostatistics and Data Science, Institute for Informatics, Data Science, and Biostatistics, Washington University School of Medicine and Washington University School of Medicine, Division of Rheumatology, Department of Medicine, St Louis, MO, 12Washington University School of Medicine, Division of Rheumatology, Department of Medicine, St Louis, MO

Meeting: ACR Convergence 2024

Keywords: Access to care, autoimmune diseases, Social support, socioeconomic factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Healthcare Disparities in Rheumatology Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: The purpose of this study was to pilot test a patient-reported social risk factor (SRF) screening tool among rheumatology outpatients and to examine the distribution of SRFs in patients with autoimmune diseases. It is well documented that adverse social determinants of health can negatively impact patients with autoimmune conditions. Thus, screening patients for SRFs could improve outcomes for patients.

Methods: A SRF screening tool was distributed and completed via the MyChart patient portal of the electronic health record (EHR), a text messaging link on patients’ mobile phones, or iPads in clinic. Patients were screened for four core SRF domains (financial strain, housing instability, food insecurity, transportation needs) and four supplemental SRF domains (physical inactivity, social isolation, stress, depression). Aggregate data from the EHR was extracted for all patients with at least one domain screened and who were seen by a participating rheumatology provider between January 1, 2023 and October 31, 2023. Descriptive statistics of SRFs were calculated. Multivariable logistic regressions were used to examine associations between sociodemographic, clinical characteristics and each SRF.

Results: During our initial pilot phase, 148 out of 187 patients were screened (79%). Only three patients outright refused screening. The final analytic sample included 483 individuals with an average age of 50 years old and 84% female (Figure 1). Eighty-four percent of patients screened positive for at least one SRF and the median number of SRFs was 2 (IQR: 1, 4). Physical inactivity (73%, 311/429), and social isolation (58%, 212/367) were the most common SRFs. Among the Core SRF domains, prevalences were 35% for financial strain (145/412), 22% for housing instability (82/370), 23% for food insecurity (96/420), and 11% for transportation needs (48/427) (Figure 2). Patients with Black race, Medicaid insurance, non-married, and younger age had higher reported SRFs than patients with White race, other insurance types, married, and older age respectively (Figure 3). Multivariate analyses showed that Medicaid insurance increased odds of reporting SRFs in all 4 core domains. Black versus White race, was associated with increased odds of reporting food insecurity and housing instability. Primary clinic diagnosis was not associated with increased odds for reporting SRFs.

Conclusion: Our SRF screening program identified a high burden of SRFs among this rheumatology patient population. This study gives a new level of detail into our patients’ barriers and possible needs. It provides immediately actionable data for providers and clinical social workers. This was successfully implemented in several rheumatology clinics using existing EHR tools, and assistance from clinic staff. Future work should seek to uncover associations between SRFs and clinical outcomes, and further interventions to address SRFs should be developed. 

Supporting image 1

Figure 1: Demographics of all respondents

Supporting image 2

Figure 2: Percentage of respondents with Core and Supplemental SRF Domains in total sample size. Financial Strain N= 412, Food Insecurity N=412, Housing Instability N=370, Transportation Needs N= 427, Physical Inactivity N= 429, Social Isolation N=367, Stress N=418, Depression N=450

Supporting image 3

Figure 3: Percentage of respondents with Core Domain SRFs by sociodemographic characteristic. a) by Race either Black, White or other, b) by insurance type either Medicaid, Medicare or Managed Care, c) by marital status either divorced/widowed/separated, never married, or married/in a committed relationship, and d) by age either 18_39 yo, 40-64 yo, or 65+. *Unknown categories excluded


Disclosures: A. Chandler: None; M. Hamid: None; A. Jiao: None; K. Hulcher: None; I. Sharma: None; P. Odom: None; A. Robinson: None; S. Kellahan: None; M. Kepper: None; C. Dostal: None; S. Fenelon: None; S. Eisen: None; D. Lew: Arthritis Foundation, 5; A. Kim: Amgen, 2, ANI Pharmaceuticals, 2, AstraZeneca, 5, Atara Bio, 2, Aurinia Pharmaceuticals, 2, Cargo Therpeutics, 2, Exagen Diagnostics, 2, 6, GSK, 2, 5, 6, Kypha, 2, 4, 10, Miltenyi Biotech, 2, Novartis, 5, Pfizer, 2, Synthekine, 2, Techtonic Therapeutics, 2, The Rheumatology Education Group, 6.

To cite this abstract in AMA style:

Chandler A, Hamid M, Jiao A, Hulcher K, Sharma I, Odom P, Robinson A, Kellahan S, Kepper M, Dostal C, Fenelon S, Eisen S, Lew D, Kim A. Patient-reported Social Risk Factor Screening Among Rheumatology Outpatients [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/patient-reported-social-risk-factor-screening-among-rheumatology-outpatients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-reported-social-risk-factor-screening-among-rheumatology-outpatients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology